Delivery Order SPE2DB20D2104-SPE2DB25FMSDF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $31,805.90 to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The contract is scheduled for ultimate completion on June 3, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) valued at $141,757, with a firm fixed price structure and no set-aside designation. The award was issued on July 30, 2025, with an ultimate completion date of July 31, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under a larger contracting vehicle supporting the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $35,020.92 to AmerisourceBergen Drug Corp for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This firm fixed-price delivery order, executed on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,248.66 on May 16, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed price, non-set-aside contract with an ultimate completion date of May 19, 2025, and performance to be executed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a $34,787.81 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Biktarvy 50-200-25 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 25, 2025. The contract is performed from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) valued at $56,371.98 under a firm fixed price contract type. The award, made on June 26, 2025, with an ultimate completion date of June 27, 2025, represents a non-competitive delivery order utilizing an existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- The Defense Logistics Agency awarded a delivery order valued at $3,725.92 to AmerisourceBergen Drug Corp for the supply of BIKTARVY 50-200-25 mg tablets (30-count units). This firm fixed-price delivery order, issued on August 12, 2025, represents a non-competitive set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025. BIKTARVY is an antiretroviral medication used in HIV treatment, reflecting the breadth...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units, valued at $17,229.27. This firm fixed price delivery order, with an ultimate completion date of August 26, 2025, represents a competitively awarded contract with no set-aside designation. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, and the contract falls under the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,111.32 to AmerisourceBergen Drug Corp for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with an ultimate completion date of July 15, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $10,627.40 to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) on August 18, 2025, with completion scheduled for August 19, 2025. This firm fixed-price, competitively awarded contract with no set-aside designation leverages AmerisourceBergen's position as a major pharmaceutical distributor supporting federal medical procurement. The work will be performed at the company's corporate office in...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMSDFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of BIKTARVY 50-200-25 mg tablets (30-count units) with a ceiling value of $11,939.20. This competitively awarded, firm fixed-price delivery order is non-set-aside and carries an ultimate completion date of June 2, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor within the federal medical procurement system, particularly for military and veteran healthcare organizations. This delivery order operates under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 billion through December 2026. This prime contract vehicle enables comprehensive pharmaceutical and medical supply support globally to military healthcare programs and government healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The smaller delivery order for BIKTARVY, an antiretroviral medication used in HIV treatment regimens, represents a routine pharmaceutical procurement leveraging this expansive global pharmaceutical support framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.9k | 5/30/25 |